Magical Trade
Monday, August 8, 2022
  • Home
  • Trade News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
  • Home
  • Trade News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Magical Trade
No Result
View All Result
Home Trade News

Pfizer submits FDA application for emergency approval of Covid treatment pill

by
November 16, 2021
in Trade News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

RELATED POSTS

Here are Monday’s biggest analyst calls: Tesla, Amazon, First Solar, Roku, Apple, Carvana & more

Palantir shares fall more than 14% following earnings report

Pfizer CEO Albert Bourla addresses a press conference after a visit to oversee the production of the Pfizer-BioNtech COVID-19 vaccine at the factory of U.S. pharmaceutical company Pfizer in Puurs, Belgium April 23, 2021.

John Thys | Pool | Reuters

Pfizer on Tuesday submitted its application to the Food and Drug Administration for emergency authorization of its Covid-19 treatment pill.

The pill, if authorized by the FDA, would be the first oral antiviral drug of its kind specifically designed to combat Covid, according to the company.

Known as Paxlovid, the pill cut the risk of hospitalization from Covid by 89% in high-risk adults who were exposed to the virus when taken in combination with a widely used HIV drug, according to the company.

“We are moving as quickly as possible in our effort to get this potential treatment into the hands of patients, and we look forward to working with the U.S. FDA on its review of our application, along with other regulatory agencies around the world,” Pfizer CEO Albert Bourla said in a statement Tuesday.

Bourla had previously said that Pfizer planned to submit its data to the FDA before Thanksgiving.

Earlier Tuesday, Pfizer announced that it would allow generic manufacturers to supply its antiviral pill, known as Paxlovid, to 95 low and middle-income countries.

This is breaking news. Please Check back for updates.

ShareTweetPin

Related Posts

Here are Monday’s biggest analyst calls: Tesla, Amazon, First Solar, Roku, Apple, Carvana & more

by
August 8, 2022
0

Here are the biggest calls on Wall Street on Monday: Canaccord reiterates Tesla as buy Canaccord raised its price target...

Palantir shares fall more than 14% following earnings report

by
August 8, 2022
0

In this article PLTR A banner featuring the logo of Palantir Technologies (PLTR) is seen at the New York Stock...

Goldman Sachs says buy this biopharma stock that’s poised to rally nearly 40% from here

by
August 8, 2022
0

Goldman Sachs says it's time for investors to put their money in Rhythm Pharmaceuticals as shares can rally nearly 40%...

Four High Frequency Indicators for the Economy

by
August 8, 2022
0

by Calculated Risk on 8/08/2022 08:13:00 AM These indicators are mostly for travel and entertainment. It is interesting to watch...

August 8th Update: Housing Inventory Increases Slow

by
August 8, 2022
0

by Calculated Risk on 8/08/2022 08:49:00 AM Inventory is still increasing, but the inventory build has slowed. Here are the...

Next Post

Qualcomm hits record high after it tells investors it will grow without Apple

Walmart says it's ready for holidays -- but hasn't yet seen huge wave of early shoppers

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:



By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • Forget Tesla — this auto stock is the one to buy right now, analyst says

    0 shares
    Share 0 Tweet 0
  • Fund manager believes FAANG is dead — says now it’s all about MANTA

    0 shares
    Share 0 Tweet 0
  • Bank of America names its top global tech stocks — including one it says has upside of 100%

    0 shares
    Share 0 Tweet 0
  • ‘Conviction sell’: UBS says avoid these global stocks amid rising headwinds

    0 shares
    Share 0 Tweet 0
  • Goldman Sachs "Will Higher Rates Put Out the Housing Fire?"

    0 shares
    Share 0 Tweet 0
  • Home
  • Trade News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by www.magicaltrade.net
No Result
View All Result
  • Email Whitelisting
  • Home
  • Privacy Policy

All rights reserved by www.magicaltrade.net